Kaempferol promotes the expression of miR-339-5p, which in turn, directly targets hnRNPA1 and PTBP1, diminishing the expression of PKM2 and inducing the expression of PKM1, thus inhibiting glycolysis and the growth of colorectal cancer [53]. This evidence concerns the gene PTBP1 and colorectal cancer.